Identification of the metabolites of anti-inflammatory compound clematichinenoside AR in rat intestinal microflora

Biomedical Chromatography

Volumn 27, Issue 12, 2013, Pages 1767-1774

  Li, Feng ^a   Wang, Dawei ^b   Xu, Ping ^a   Wu, Jie ^b   Liu, Li ^a   Liu, Xiaodong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Jiangsu Provincial Institute of Traditional Chinese Medicine   (China)

Author keywords

Clematichinenoside AR; Intestinal microflora; LC Q TOF MS; Metabolite identification

Indexed keywords

BIOMOLECULES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICINE; RATS;

ACTIVE COMPONENTS; ANTI-INFLAMMATORIES; CLEMATICHINENOSIDE AR; INTESTINAL MICROFLORA; LC-Q-TOF MS; METABOLITE IDENTIFICATION; MICROFLORAE; PENTACYCLIC TRITERPENOIDS; TRADITIONAL CHINESE MEDICINE; TRITERPENOID SAPONINS;

METABOLITES;

ANTIINFLAMMATORY AGENT; CLEMATICHINENOSIDE AR; DRUG METABOLITE; SAPONIN DERIVATIVE; TERPENOID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DEGLYCOSYLATION; DRUG DETERMINATION; DRUG METABOLISM; DRUG TRANSFORMATION; IN VITRO STUDY; INTESTINE FLORA; LARGE INTESTINE; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; QUADRUPOLE MASS SPECTROMETRY; RAT; TIME OF FLIGHT MASS SPECTROMETRY;

RATTUS;

CLEMATICHINENOSIDE AR; INTESTINAL MICROFLORA; LC-Q/TOF MS; METABOLITE IDENTIFICATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOTRANSFORMATION; CHROMATOGRAPHY, LIQUID; GASTROINTESTINAL CONTENTS; GLYCOSYLATION; MALE; MASS SPECTROMETRY; MICROBIOTA; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS;

EID: 84887135193     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2991     Document Type: Article

References (15)

1. Hasegawa H and Uchiyama M. Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Medica 1998; 64: 696-700.
2. He JX, Goto E, Akao T and Tani T. Interaction between Shaoyao-Gancao-Tang and a laxative with respect to alteration of paeoniflorin metabolism by intestinal bacteria in rats. Phytomedicine 2007; 14: 452-459.
3. Kim YS, Kim JJ, Cho KH, Jung WS, Moon SK, Park EK and Kim DH. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. Journal of Microbiology and Biotechnology 2008; 18: 1109-1114.
4. Kobashi K, Akao T, Hattori M and Namba T. Metabolism of drugs by intestinal bacteria. Bifidobacteria and Microflora 1992; 11: 9-23.
5. Liu H, Wang K, Tang Y, Sun Z, Jian L, Li Z, Wu B and Huang C. Structure elucidation of in vivo and in vitro metabolites of mangiferin. Journal of Pharmaceutical and Biomedical Analysis 2011; 55: 1075-1082.
6. Liu LF, Ma XL, Wang YX, Li FW, Li YM, Wan ZQ and Tang QL. Triterpenoid saponins from the roots of Clematis chinensis Osbeck. Journal of Asian Natural Product Research 2009; 11: 389-396.
7. Lu XY, Sun DL, Chen ZJ, Chen T, Li LP, Xu ZH, Jiang HD and Zeng S. Relative contribution of small and large intestine to deglycosylation and absorption of flavonoids from Chrysanthemun morifolium extract. Journal of Agriculture and Food Chemistry 2010; 58: 10661-10667.
8. Lv XFW, Li YM, Liu LF and Li FW. Analgesic and anti-inflammatory effect of clematichinenoside. Chinese Journal of New Drugs 2009; 18: 1535-1539.
9. Odani T, Tanizawa H and Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. III. The absorption, distribution and excretion of ginsenoside Rb1 in the rat. Chemical & Pharmaceutical Bulletin (Tokyo) 1983; 31: 1059-1066.
10. Peng C, Perera PK, Li YM, Fang WR, Liu LF and Li FW. Anti-inflammatory effects of Clematis chinensis Osbeck extract(AR-6) may be associated with NF-kappaB, TNF-alpha, and COX-2 in collagen-induced arthritis in rat. Rheumatology International 2011; 32: 3119-3125.
11. Shi S, Jiang D, Dong C and Tu P. Triterpene saponins from clematis mandshurica. Journal of Natural Products 2006; 69: 1591-1595.
12. Sun SX, Li YM, Fang WR, Cheng P, Liu L and Li F. Effect and mechanism of AR-6 in experimental rheumatoid arthritis. Clinical and Experimental Medicine 2010; 10: 113-121.
13. The State Pharmacopoeia Committee of P. R. China. Chinese Pharmacopoeia, Vol. 1. China Medical Science Press: Beijing, 2010; 234-235 .
14. Wang D, Li F, Li P, Zhang J, Liu L, Xu P, Zhou L and Liu X. Validated LC-MS/MS assay for the quantitative determination of clematichinenoside AR in rat plasma and its application to a pharmacokinetic study. Biomedical Chromatography 2012; 26: 1282-1285.
15. Yu Y, Liu L, Wang X, Liu X, Xie L and Wang G. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochemical Pharmacology 2010; 79: 1000-1006.